# Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.

> **NCT01993173** · PHASE3 · COMPLETED · sponsor: **Sanofi Pasteur, a Sanofi Company** · enrollment: 1440 (actual)

## Conditions studied

- Diphtheria
- Tetanus
- Pertussis

## Interventions

- **BIOLOGICAL:** Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine Adsorbed Tdap (ADACEL)
- **BIOLOGICAL:** DT vaccine (Diphtheria and Tetanus Combined Vaccine, Adsorbed)
- **BIOLOGICAL:** Td vaccine (Diphtheria and Tetanus Combined Vaccine for Adults and Adolescents, Adsorbed)

## Key facts

- **NCT ID:** NCT01993173
- **Lead sponsor:** Sanofi Pasteur, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2014-02
- **Final completion:** 2015-04
- **Target enrollment:** 1440 (ACTUAL)
- **Last updated:** 2015-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01993173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01993173, "Sanofi Pasteur's Tdap Combined Vaccine as a Booster Versus Local DT Vaccine in Children or Versus Local Td Vaccine in Adolescents and Adults in China.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01993173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*